CINECA IRIS Institutional Research Information System

FERRANNINI, ELEUTERIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 44.430
AS - Asia 22.931
EU - Europa 15.623
SA - Sud America 3.174
AF - Africa 529
OC - Oceania 67
Continente sconosciuto - Info sul continente non disponibili 19
Totale 86.773
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 43.035
SG - Singapore 6.804
CN - Cina 6.781
IT - Italia 4.928
HK - Hong Kong 3.765
BR - Brasile 2.683
SE - Svezia 2.319
BG - Bulgaria 1.707
VN - Vietnam 1.622
TR - Turchia 1.162
DE - Germania 1.148
UA - Ucraina 1.146
CA - Canada 1.109
KR - Corea 1.032
GB - Regno Unito 912
FI - Finlandia 899
RU - Federazione Russa 753
FR - Francia 747
CH - Svizzera 488
IN - India 389
BD - Bangladesh 244
JP - Giappone 221
IQ - Iraq 174
AR - Argentina 154
MX - Messico 125
PK - Pakistan 106
AT - Austria 101
SA - Arabia Saudita 94
BE - Belgio 84
CI - Costa d'Avorio 82
NL - Olanda 74
UZ - Uzbekistan 74
EC - Ecuador 72
ZA - Sudafrica 72
MA - Marocco 70
VE - Venezuela 67
CO - Colombia 64
ID - Indonesia 63
PL - Polonia 63
SN - Senegal 60
ES - Italia 57
KE - Kenya 53
AU - Australia 52
JO - Giordania 47
EG - Egitto 46
NP - Nepal 38
GR - Grecia 35
PY - Paraguay 34
IE - Irlanda 33
AE - Emirati Arabi Uniti 30
CL - Cile 30
IL - Israele 30
TN - Tunisia 30
JM - Giamaica 29
PE - Perù 29
UY - Uruguay 29
PH - Filippine 26
DZ - Algeria 24
BJ - Benin 22
MY - Malesia 22
OM - Oman 21
TT - Trinidad e Tobago 21
KZ - Kazakistan 20
CR - Costa Rica 19
ET - Etiopia 18
CZ - Repubblica Ceca 17
LB - Libano 16
RO - Romania 16
AL - Albania 15
AZ - Azerbaigian 15
BH - Bahrain 14
EU - Europa 14
HU - Ungheria 14
LT - Lituania 14
PA - Panama 14
KW - Kuwait 13
NG - Nigeria 13
PS - Palestinian Territory 13
TW - Taiwan 13
DO - Repubblica Dominicana 12
NZ - Nuova Zelanda 12
HN - Honduras 11
TH - Thailandia 11
BO - Bolivia 10
DK - Danimarca 9
MN - Mongolia 9
PT - Portogallo 9
GE - Georgia 8
GT - Guatemala 8
IR - Iran 8
KG - Kirghizistan 8
BB - Barbados 7
BS - Bahamas 7
RS - Serbia 7
SV - El Salvador 7
AM - Armenia 6
BN - Brunei Darussalam 6
GA - Gabon 6
MD - Moldavia 6
NI - Nicaragua 6
Totale 86.662
Salva come PNG Salva come JPEG
Città #
Fairfield 4.810
Ashburn 4.707
Singapore 3.900
Hong Kong 3.726
Woodbridge 3.443
Chandler 2.573
Ann Arbor 2.315
Houston 2.280
Milan 2.072
San Jose 2.012
Seattle 1.944
Sofia 1.703
Cambridge 1.594
Wilmington 1.592
Santa Clara 1.548
Jacksonville 1.520
Dallas 1.495
Hefei 1.292
Shanghai 1.244
Beijing 1.226
Seoul 1.008
New York 956
Ottawa 956
Izmir 756
Boardman 731
Serra 694
Princeton 687
Lawrence 636
Nanjing 617
Medford 610
Lauterbourg 540
Los Angeles 508
Bern 461
Des Moines 426
Ho Chi Minh City 319
Buffalo 296
Istanbul 282
Dearborn 264
Jüchen 257
Nanchang 253
Hanoi 251
San Diego 229
Dong Ket 222
São Paulo 220
Tokyo 195
Redondo Beach 177
The Dalles 177
Falls Church 170
Rome 167
Helsinki 166
Columbus 160
Munich 158
Council Bluffs 151
Kunming 151
Shenyang 129
London 125
Hebei 114
Boulder 113
Chicago 105
Tianjin 97
Frankfurt am Main 93
Ogden 92
Redwood City 92
Changsha 91
Jiaxing 83
Abidjan 82
Rio de Janeiro 79
Florence 78
Brussels 75
Washington 74
Pisa 73
Norwalk 72
Lancaster 70
Vienna 69
Dhaka 68
Tashkent 65
Baghdad 64
Belo Horizonte 62
Da Nang 62
Dakar 59
Hangzhou 59
Pune 59
Nuremberg 53
Brasília 49
Orange 49
Guangzhou 48
Curitiba 47
Haiphong 45
Warsaw 45
Nairobi 44
San Francisco 44
Zhengzhou 40
Auburn Hills 39
Jinan 38
Porto Alegre 38
Düsseldorf 36
Lahore 36
Orem 36
Verona 36
Amman 35
Totale 63.909
Salva come PNG Salva come JPEG
Nome #
Rationale and design of the ADVANCE study: a randomised trial of blood pressure lowering and intensive glucose control in high-risk individuals with type 2 diabetes mellitus 318
F-18-FDG assessment of glucose disposal and production rates during fasting and insulin stimulation: A validation study 271
[C-11]palmitate kinetics across the splanchnic bed in arterial, portal and hepatic venous plasma during fasting and euglycemic hyperinsulinemia 260
Hepatitis C Virus Infection: Evidence for an Association With Type 2 Diabetes: Response to Skowronski et al. 247
Quantification of liver glucose metabolism by positron emission tomography: Validation study in pigs 247
Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance 241
Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects 231
EFFECT OF FATTY-ACIDS ON GLUCOSE-PRODUCTION AND UTILIZATION IN MAN 229
Increase of circulating CXCL9 and CXCL11 associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis. 227
THE THEORETICAL BASES OF INDIRECT CALORIMETRY - A REVIEW 220
Reduced left ventricular functional reserve in hypertensive patients with preserved function at rest 219
Biliopancreatic diversion in nonobese patients with type 2 diabetes: impact and mechanisms. 218
SPLANCHNIC AMINO-ACID AND GLUCOSE-METABOLISM DURING AMINO-ACID INFUSION IN DOGS 214
Insulin resistance and hyperinsulinemia - No independent relation to left ventricular mass in humans 213
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans - A quantitative study 212
RESPONSE TO INTRAVENOUS GLUCOSE OF PATIENTS ON MAINTENANCE HEMODIALYSIS - EFFECTS OF DIALYSIS 211
PATTERN OF INSULIN DELIVERY AFTER INTRAVENOUS GLUCOSE INJECTION IN MAN AND ITS RELATION TO PLASMA-GLUCOSE DISAPPEARANCE 211
INSULIN RESISTANCE, INSULIN DEFICIENCY AND THE PATHOGENESIS OF DIABETES-MELLITUS 210
LACK OF EFFECT OF PARATHYROID-HORMONE ON HEPATIC GLUCOSE-METABOLISM IN THE DOG 209
Skin Vasodilator Function and Vasomotion in Patients with Morbid Obesity: Effects of Gastric Bypass Surgery 208
ADRENERGIC-BLOCKADE ALTERS GLUCOSE KINETICS DURING EXERCISE IN INSULIN-DEPENDENT DIABETICS 207
PARENTAL HISTORY OF DIABETES IS ASSOCIATED WITH INCREASED CARDIOVASCULAR RISK-FACTORS 206
Recombinant human TSH reduces endothelium-dependent vasodilation in patients monitored for differentiated thyroid carcinoma 206
Effect of 1-year treatment with interferon-beta 1b on thyroid function and autoimmunity in patients with multiple sclerosis 206
REGULATION OF SPLANCHNIC AND PERIPHERAL GLUCOSE-UPTAKE BY INSULIN AND HYPERGLYCEMIA IN MAN 205
INSULIN ACTION AND SUBSTRATE COMPETITION 204
THE DISPOSAL OF AN ORAL GLUCOSE-LOAD IN HEALTHY-SUBJECTS - A QUANTITATIVE STUDY 202
ACUTE RESPIRATORY-DISTRESS SYNDROME IN AN ADULT PATIENT WITH A MYELODYSPLASTIC DISORDER 201
MECHANISM OF IMPROVEMENT IN GLUCOSE-METABOLISM AFTER CHRONIC GLYBURIDE THERAPY 201
SODIUM ELEVATES THE PLASMA-GLUCOSE RESPONSE TO GLUCOSE-INGESTION IN MAN 199
ACUTE ELEVATION OF FREE FATTY-ACID LEVELS LEADS TO HEPATIC INSULIN RESISTANCE IN OBESE SUBJECTS 199
A MODEL OF GLUCOSE KINETICS AND THEIR CONTROL BY INSULIN, COMPARTMENTAL AND NONCOMPARTMENTAL APPROACHES 198
HEPATIC AND EXTRAHEPATIC SPLANCHNIC GLUCOSE-METABOLISM IN THE POSTABSORPTIVE AND GLUCOSE FED DOG 197
OPERATION OF RANDLES CYCLE IN PATIENTS WITH NIDDM 197
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects 197
Adipocyte P2X(7) receptors expression: A role in modulating inflammatory response in subjects with metabolic syndrome? 196
HEPATIC AND PERIPHERAL INSULIN RESISTANCE - A COMMON FEATURE OF TYPE-2 (NON-INSULIN-DEPENDENT) AND TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS 195
TRANSIENT HEPATIC RESPONSE TO GLUCAGON IN MAN - ROLE OF INSULIN AND HYPERGLYCEMIA 195
Thiazolidinediones improve beta-cell function in type 2 diabetic patients 195
alpha-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population 195
DIFFERENTIAL-EFFECTS OF INSULIN AND HYPERGLYCEMIA ON INTRACELLULAR GLUCOSE DISPOSITION IN HUMANS 194
IMPAIRED INSULIN DEGRADATION IN A PATIENT WITH INSULIN RESISTANCE AND ACANTHOSIS NIGRICANS 193
EFFECT OF INSULIN AND GLUCOSE ON FEEDING-BEHAVIOR 193
Physical activity and insulin sensitivity - the RISC Study 193
Daylong pituitary hormones in morbid obesity: effects of bariatric surgery 193
Sibutramine lost and found 191
THE PATHOGENESIS OF NON-INSULIN-DEPENDENT DIABETES 190
Effects of insulin on the kidney and the cardiovascular system 190
Physiology of glucose homeostasis and insulin therapy in type 1 and type 2 diabetes. 190
Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance 189
Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes. 189
Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: An endocrine society clinical practice guideline 188
Cytokines (interferon-γ and tumor necrosis factor-α)-induced nuclear factor-κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone 187
Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of L-T-4 replacement therapy 186
INFLUENCE OF LONG-TERM DIABETES ON LIVER-GLYCOGEN METABOLISM IN THE RAT 184
Extra-ocular muscle cells from patients with Graves' ophthalmopathy secrete α (CXCL10) and β (CCL2) chemokines under the influence of cytokines that are modulated by PPARγ 184
Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects 183
Insulin: new roles for an ancient hormone 183
INTERNAL BILIARY DIVERSION IMPROVES GLUCOSE-TOLERANCE IN THE RAT 182
Long-term follow-up of 106 multiple sclerosis patients undergoing IFN-ß 1a or 1b therapy: predictive factors of thyroid disease development and duration 182
METABOLIC EFFECTS OF LOW-DOSE INSULIN THERAPY ON GLUCOSE-METABOLISM IN DIABETIC-KETOACIDOSIS 181
RELATION OF BIRTH-WEIGHT TO MATERNAL PLASMA-GLUCOSE AND INSULIN CONCENTRATIONS DURING NORMAL-PREGNANCY 180
Effects of hemodialysis and vitamin E supplementation on low-density lipoprotein oxidizability in end-stage renal failure. 180
Differential effect of weight loss on insulin resistance in surgically treated obese patients 180
Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis 179
Adiponectin and left ventricular structure and function in healthy adults 179
Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects 178
Independent stimulation of glucose metabolism and Na+-K+ exchange by insulin in the human forearm. 178
Beta-cell function in obesity: effects of weight loss 176
Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients 176
SYNERGISTIC INTERACTION BETWEEN EXERCISE AND INSULIN ON PERIPHERAL GLUCOSE-UPTAKE 175
Effect of Interferon-alpha and -beta on NIS, TPO and Thyroglobulin expression in primary human thyroid cell cultures 175
Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function 175
Long-term effects of bariatric surgery on meal disposal and beta-cell function in diabetic and nondiabetic patients. 175
Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation 174
Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control 174
Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer. 174
TIME-DEPENDENCE OF THE INTERACTION BETWEEN LIPID AND GLUCOSE IN HUMANS 173
Hypertension, insulin resistance, and diabetes 172
Fasting-based estimates of insulin sensitivity in overweight and obesity: A critical appraisal 172
POSTPERICARDIECTOMY SYNDROME IN A PATIENT WITH RADIATION-INDUCED PERICARDIAL-EFFUSION 171
INFLUENCE OF PLASMA-GLUCOSE AND INSULIN CONCENTRATION ON PLASMA-GLUCOSE CLEARANCE IN MAN 171
METABOLIC BASIS OF OBESITY AND NONINSULIN-DEPENDENT DIABETES-MELLITUS 171
Acute insulin administration does not affect plasma leptin levels in lean or obese subjects 171
Rosiglitazone increases matrix production and quenches inflammation: studies in human cells 171
INSULIN KINETICS AND GLUCOSE-INDUCED INSULIN DELIVERY IN CHRONICALLY DIALYZED SUBJECTS - ACUTE EFFECTS OF DIALYSIS 170
Effect of acute hyperglycemia on insulin secretion in humans 170
Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism 170
Effects of short and prolonged mild intracellular nitric oxide manipulations on various aspects of insulin secretion in INS-1E β-cells. 170
Quantification of D-mannose in plasma: Development and validation of a reliable and accurate HPLC-MS-MS method 170
EFFECTS OF PHYSIOLOGICAL PLASMA-INSULIN LEVELS ON GLUCOSE-TURNOVER PARAMETERS IN FAMILIAL HYPERCHOLESTEROLEMIA 169
Hyperinsulinemia and autonomic nervous system dysfunction in obesity - Effects of weight loss 169
γ-Glutamyltransferase Fractions in Obese Subjects with Type 2 Diabetes: Relation to Insulin Sensitivity and Effects of Bariatric Surgery 169
Plasma N-Acetylaspartate Is Related to Age, Obesity, and Glucose Metabolism: Effects of Antidiabetic Treatment and Bariatric Surgery 169
LACK OF A GASTROINTESTINAL MEDIATOR OF INSULIN ACTION IN MATURITY-ONSET DIABETES 168
Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. 168
Troglitazone reduces LDL oxidation and lowers plasma E-selectin concentration, in NIDDM patients 167
Identification of individuals with insulin resistance using routine clinical measurements 167
beta-cell function in morbidly obese subjects during free living - Long-term effects of weight loss 167
Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach 167
Totale 19.292
Salva come PNG Salva come JPEG
Categoria #
all - tutte 252.411
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 252.411
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021831 0 0 0 0 0 0 0 0 0 0 0 831
2021/20226.921 99 372 166 482 1.405 1.004 138 354 396 210 314 1.981
2022/20236.532 923 645 328 631 867 1.014 59 513 1.054 56 372 70
2023/20246.556 1.153 887 902 486 1.025 1.011 49 234 121 71 75 542
2024/202517.384 48 728 78 862 1.242 1.689 1.363 1.183 1.819 2.455 2.133 3.784
2025/202617.597 1.687 2.884 2.092 1.117 1.290 2.003 2.617 823 716 1.583 555 230
Totale 87.486